IL15 and Miyoshi myopathy: To improve NK cell killing capacity against MM cells, we then stimulated both patient and donor NK cells for 7 days with IL-2/15 cytokine cocktail (IL-2: 100 U/ml; IL-15: 10 ng/ml) prior to performing the killing assay (Figure 1B).